Medicenna Therapeutics Corp (MDNAF OTCQX) stock market data APIs
$0.315
0(0%)
as of June 8, 2026
Try our APIs with
free plan!
Medicenna Therapeutics Corp Financial Data Overview
Price chart is built with
Anychart
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Prev. Close
0.315
Open
0.3151
High
0.3159
Low
0.3134
52 wk Range
0.265-1.43
Market Cap
26 611 K
Shares Outstanding
83 420 K
EPS
-0.04
Beta
1.854
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Medicenna Therapeutics Corp data using free add-ons & libraries
Get Medicenna Therapeutics Corp Fundamental Data
Medicenna Therapeutics Corp Fundamental data includes:
- Net Revenue:
- EBITDA: -22 310 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Medicenna Therapeutics Corp Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-02-12
- EPS/Forecast: -0.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medicenna Therapeutics Corp News
New
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
Medicenna Therapeutics Corp. TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage ...
Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvi...
Medicenna To Present Updated Bizaxofusp Data At 7th Annual Glioblastoma Development Summit
(RTTNews) - Medicenna Therapeutics Corp. (MDNAF), a clinical-stage immunotherapy company, will present updated internal and external data sets related to Bizaxofusp (MDNA55) at the 7th Annual Glioblas...
Medicenna Therapeutics GAAP EPS of -C$0.06
* Medicenna Therapeutics press release [https://seekingalpha.com/pr/20305705-medicenna-therapeutics-reports-second-quarter-fiscal-2026-financial-results-and-provides-a] (OTCQB:MDNAF [https://seeking...
Get Medicenna Therapeutics Corp fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
